Blockade of the angiotensin II (ANG II) type 1 receptor (AT1) has been shown to restore
baroreflex sensitivity in rats and rabbits with experimental chronic heart failure (CHF) …

Because the renin-angiotensin system is activated in heart failure, we hypothesized that
angiotensin II (ANG II) plays a role in altering baroreflex sensitivity in the setting of heart …

Enhanced sympathetic outflow is seen in both patients with congestive heart failure and
animals with experimental heart failure. In a previous study, we demonstrated that the …

Sympatho‐excitation is a hallmark of the chronic heart failure (CHF) state. It has long been
assumed that this sympatho‐excitation is mediated by a reduction in sensory input from …

The effect of chronic activation or inhibition of central ANG II receptors on cardiac baroreflex
function in conscious normotensive rabbits was examined. Animals received a fourth …

It has been established that the baroreflex is markedly decreased in chronic heart failure
(CHF). Our recent study has indicated that activation of the cardiac sympathetic afferent …

During angiotensin II (Ang II)-induced elevation of arterial pressure, there is an attenuation
of the baroreflex control of heart rate (HR), but the site of this action of Ang II on the …

Exercise training (EX) has become an important modality capable of enhancing the quality
of life and survival of patients with chronic heart failure (CHF). Although 4 wk of EX in …

Intravenous injection of angiotensin II type 1 (AT1) receptor antagonist improves the
baroreceptor reflex gain in spontaneously hypertensive rats (SHRs). To investigate the role …

This study reports the effects of angiotensin II (ANG II), arginine vasopression (AVP),
phenylephrine (PE), and sodium nitroprusside (SNP) on baroreflex control of heart rate in …